title: Does paclitaxel decrease the interstitial fluid pressure and improve oxygenation in breast cancer in a schedule-dependent fashion?
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
authors.forename: Ozden
authors.initials: O
authors.lastname: Altundag
authors.forename: Selahattin
authors.initials: S
authors.lastname: Turen
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D019069:Cell Respiration / Q000187:drug effects; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D045604:Extracellular Fluid / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D009997:Osmotic Pressure / Q000187:drug effects; D010084:Oxidation-Reduction / Q000187:drug effects; D010100:Oxygen / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D017239:Paclitaxel / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D017239:Paclitaxel; D010100:Oxygen